Company Press Release

CHANDRASHEKARAN NAMED DIRECTOR OF QUANTITATIVE RESEARCH FOR AMERICAN CENTURY INVESTMENTS

KANSAS CITY, Mo., April 26, 2013 — American Century Investments has named former BlackRock/Barclays Global Investors (BGI) executive Vinod Chandrashekaran, Ph.D., senior vice president and director of quantitative research. In his role, Chandrashekaran leads the quantitative research efforts for American Century’s Quantitative Equity discipline and is responsible for maintaining and enhancing the security selection models used by the quantitative equity strategies. He also is being named co-portfolio manager for American Century’s Non-U.S. Systematic Large Cap Value (International Value) and Non-U.S. Large Cap Core (International Core) strategies.

Reporting to Chief Investment Officer for Asset Allocation and Quantitative Equity Scott Wittman, CFA, CAIA, Chandrashekaran’s appointment was effective April 22. He is based in Mountain View, Calif., home to the firm’s quantitative equity portfolio management team.

“Vinod brings substantial quantitative expertise to his role, having developed, managed and enhanced security selection and risk models at various well-respected quantitative firms,” said Wittman. “He also brings experience in the areas of implementation research and risk-management, which will complement our capabilities. Vinod will be a key contributor to our team as we strive to deliver strong returns on behalf of our clients.”

During his 10 years with BlackRock/BGI, Chandrashekaran served in a number of senior leadership positions. Since 2010, he’s been the head of risk management for the firm’s Quantitative Equity and Global-Macro strategies. Other roles have included head of implementation research for BGI’s Quantitative Active Equity teams and head of the U.S. Large Cap Equity portfolio management team. Previously, he was with Barra Inc., where he served as head of equity research.

Chandrashekaran holds a B.Tech (bachelor of technology) in electronics from the Indian Institute of Technology (Madras, India) and a post-graduate diploma in management from the Indian Institute of Management (Calcutta, India). He earned a master’s degree and Ph. D. in finance from the University of California at Berkeley.

Additionally, Yulin Long, Ph.D., vice president and senior quantitative analyst, is taking on additional responsibilities as co-portfolio manager of the Non-U.S. Systematic Large Cap Value (International Value) and Non-U.S. Large Cap Core (International Core) strategies with Chandrashekaran and current Portfolio Manager Elizabeth Xie, Ph.D, CFA. Long has been a member of the American Century’s quantitative research team since joining the firm in 2005. She holds a bachelor’s degree in finance from Beijing University, an M.Phil (master of philosophy) in accounting from Hong Kong University of Science and Technology and a Ph.D. in accounting from Stanford University.

-more-

Page 2/Director of Quantitative Research

Portfolio Manager Armando Lacayo, who previously served on the team managing the Non- U.S. Systematic Large Cap Value (International Value) and Non-U.S. Large Cap Core (International Core) strategies, has decided to leave the company to pursue a new career opportunity outside of the asset management industry.

American Century Investments is a leading privately held investment management firm, committed to delivering superior investment performance and building long-term client relationships since 1958. Serving investment professionals, institutions, corporations and individual investors, American Century Investments offers a variety of actively managed investment disciplines through an array of products including mutual funds, institutional separate accounts, commingled trusts and sub- advisory accounts. The company's 1,300 employees serve clients from offices in New York; London; Hong Kong; Mountain View, Calif. and Kansas City, Mo. James E. Stowers Jr. is founder of the company and Jonathan S. Thomas is president and chief executive officer. Through its ownership structure, more than 40 percent of American Century Investments' profits support research to help find cures for genetically-based diseases including cancer, diabetes and dementia. For more information, visit www.americancentury.com.